| Vol. 12.15 – 27 April, 2021 |
| |
|
|
| Researchers established a model of stepwise leukemogenesis in congenital neutropenia (CN)/acute myeloid leukemiausing CRISPR-Cas9 gene editing of CN patient-derived iPSCs. [Cell Stem Cell] |
| |
|
|
PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Using acute myleoid leukemia cell lines (AML) and leukemia stem cell-enriched blast cells from pre-treatment AML patients, investigators evaluated the effects of 8-chloro-adenosine (8-Cl-Ado), VEN and the 8-Cl-Ado/venetoclax combination on fatty acid metabolism, glycolysis and oxidative phosphorylation using liquid scintillation counting, a Seahorse XF Analyzer and gene set enrichment analysis. [Journal of Hematology & Oncology] |
|
|
|
| Researchers discovered 14 single variant-red blood cell trait associations at 12 genomic loci, which have not been reported previously. [American Journal of Human Genetics] |
|
|
|
| Scientists investigated the significance of the mode of immune-escape on T cells engineered to express chimeric antigen receptors (CAR-T) cells. [Clinical Cancer Research] |
|
|
|
| Exosomes were isolated by ultracentrifugation and ExoQuickTM and characterized by dynamic light scattering, nanoparticle tracking analysis system, scanning electron microscopy, transmission electron microscopy, EXOCETTM assay, and fluorescence polarization. [International Journal of Nanomedicine] |
|
|
|
| Investigators performed a ChIP-seq analysis of MYB in K562 cells accompanied by detailed bioinformatics analyses. They found that MYB occupied both promoters and enhancers. [Scientific Reports] |
|
|
|
| Researchers present a high throughput strategy for identifying and isolating megakaryocytes and their progenitor cells from a heterogeneous population of bone marrow samples. [Scientific Reports] |
|
|
|
| The authors characterized the human HSCs and progenitor microenvironment. They obtained three adjacent bone marrow sections from ten healthy volunteers. [PLoS One] |
| |
|
|
| Children with acute myeloid leukemia, relapsed acute lymphoblastic leukemia, or undergoing HSC transplant were systematically assessed for musculoskeletal impairments as part of Children’s Oncology Group study ACCL0934. [Pediatric Blood & Cancer] |
| |
|
|
|
| Investigators review the evidence within the hematologic malignancy field and also borrow from perspectives rooted in evolutionary biology to reframe pathogenesis of hematologic disorders as dynamic processes involving complex interplays of genetic and nongenetic subclones and the tissue microenvironment in which they reside. [Blood Cancer Discovery] |
|
|
|
|
| Ayala Pharmaceuticals, Inc. announced the dosing of the first patient in the ongoing Phase I clinical trial evaluating its potent investigational gamma secretase inhibitor, AL102, in combination with Novartis’ investigational anti-B-cell maturation antigen (BMSA) agent, WVT078, for the treatment of patients with relapsed and/or refractory multiple myeloma. [Ayala Pharmaceuticals, Inc.] |
|
|
|
| Bristol Myers Squibb announced the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended approval of Onureg® as a maintenance therapy in adult patients with acute myeloid leukemia who achieved complete remission or complete remission with incomplete blood count recovery following induction therapy with or without consolidation treatment and who are not candidates for, including those who choose not to proceed to, HSC transplantation. [Bristol Myers Squibb] |
|
|
|
| Shorla Pharma Limited announced that it has submitted, and the FDA has accepted for filing, its application for its SH-111 oncology drug designed to treat T-cell leukemia. [Shorla Pharma Limited (BusinessWire, Inc.)] |
|
|
|
|
| June 4, 2021 Shanghai, China |
|
|
|
|
|
| Zhejiang University – Zhejiang, China |
|
|
|
| Cyprus Cancer Research Institute – Cyprus Republic |
|
|
|
| Memorial Sloan Kettering Cancer Center – New York, New York, United States |
|
|
|
| Rutgers University – New Brunswick, New Jersey, United States |
|
|
|
| American Association for Cancer Research – Boston, Massachusetts, United States |
|
|
|
|